Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.

Alberti P, Canta A, Chiorazzi A, Fumagalli G, Meregalli C, Monza L, Pozzi E, Ballarini E, Rodriguez-Menendez V, Oggioni N, Sancini G, Marmiroli P, Cavaletti G.

Neuropharmacology. 2019 Dec 4:107905. doi: 10.1016/j.neuropharm.2019.107905. [Epub ahead of print]

PMID:
31811874
2.

Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral Neuropathy.

Lessans S, Lassiter CB, Carozzi V, Heindel P, Semperboni S, Oggioni N, Chiorazzi A, Thompson C, Wagner M, Holden J, Rahn E, Sweatt JD, Cavaletti G, Renn CL, Dorsey SG.

Nurs Res. 2019 Mar/Apr;68(2):145-155. doi: 10.1097/NNR.0000000000000338.

PMID:
30586060
3.

High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats.

Meregalli C, Marjanovic I, Scali C, Monza L, Spinoni N, Galliani C, Brivio R, Chiorazzi A, Ballarini E, Rodriguez-Menendez V, Carozzi VA, Alberti P, Fumagalli G, Pozzi E, Canta A, Quartu M, Briani C, Oggioni N, Marmiroli P, Cavaletti G.

J Neuroinflammation. 2018 Aug 21;15(1):232. doi: 10.1186/s12974-018-1270-x.

4.

Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy.

Monfrini M, Donzelli E, Rodriguez-Menendez V, Ballarini E, Carozzi VA, Chiorazzi A, Meregalli C, Canta A, Oggioni N, Crippa L, Avezza F, Silvani S, Bonandrini B, Figliuzzi M, Remuzzi A, Porretta-Serapiglia C, Bianchi R, Lauria G, Tredici G, Cavaletti G, Scuteri A.

Exp Neurol. 2017 Feb;288:75-84. doi: 10.1016/j.expneurol.2016.11.006. Epub 2016 Nov 13.

PMID:
27851902
5.

Age-related changes in the function and structure of the peripheral sensory pathway in mice.

Canta A, Chiorazzi A, Carozzi VA, Meregalli C, Oggioni N, Bossi M, Rodriguez-Menendez V, Avezza F, Crippa L, Lombardi R, de Vito G, Piazza V, Cavaletti G, Marmiroli P.

Neurobiol Aging. 2016 Sep;45:136-148. doi: 10.1016/j.neurobiolaging.2016.05.014. Epub 2016 May 20.

PMID:
27459934
6.

Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.

Marra A, Rossi D, Pignataro L, Bigogno C, Canta A, Oggioni N, Malacrida A, Corbo M, Cavaletti G, Peviani M, Curti D, Dondio G, Collina S.

Future Med Chem. 2016;8(3):287-95. doi: 10.4155/fmc.15.191. Epub 2016 Feb 22.

PMID:
26898712
7.

Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice.

Meregalli C, Carozzi VA, Sala B, Chiorazzi A, Canta A, Oggioni N, Rodriguez-Menendez V, Ballarini E, Ceresa C, Nicolini G, Crippa L, Orciani M, Cavaletti G, Marmiroli P.

J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):115-24.

PMID:
25864747
8.

Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models.

Carozzi VA, Chiorazzi A, Canta A, Meregalli C, Oggioni N, Cavaletti G, Marmiroli P.

Exp Neurol. 2015 Feb;264:92-102. doi: 10.1016/j.expneurol.2014.11.002. Epub 2014 Nov 18.

PMID:
25450467
9.

Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats.

Othman A, Bianchi R, Alecu I, Wei Y, Porretta-Serapiglia C, Lombardi R, Chiorazzi A, Meregalli C, Oggioni N, Cavaletti G, Lauria G, von Eckardstein A, Hornemann T.

Diabetes. 2015 Mar;64(3):1035-45. doi: 10.2337/db14-1325. Epub 2014 Oct 2.

10.

Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy.

Taiana MM, Lombardi R, Porretta-Serapiglia C, Ciusani E, Oggioni N, Sassone J, Bianchi R, Lauria G.

PLoS One. 2014 Sep 30;9(9):e108403. doi: 10.1371/journal.pone.0108403. eCollection 2014.

11.

Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy.

Meregalli C, Chiorazzi A, Carozzi VA, Canta A, Sala B, Colombo M, Oggioni N, Ceresa C, Foudah D, La Russa F, Miloso M, Nicolini G, Marmiroli P, Bennett DL, Cavaletti G.

Cell Cycle. 2014;13(4):612-21. doi: 10.4161/cc.27476. Epub 2013 Dec 12.

PMID:
24335344
12.

Antibody against tumor necrosis factor-α reduces bortezomib-induced allodynia in a rat model.

Chiorazzi A, Canta A, Meregalli C, Carozzi V, Sala B, Oggioni N, Monbaliu J, VAN DE Velde H, Cavaletti G.

Anticancer Res. 2013 Dec;33(12):5453-9.

PMID:
24324081
13.

Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells.

Figliuzzi M, Bianchi R, Cavagnini C, Lombardi R, Porretta-Serapiglia C, Lauria G, Avezza F, Canta A, Carozzi V, Chiorazzi A, Marmiroli P, Meregalli C, Oggioni N, Sala B, Cavaletti G, Remuzzi A.

Am J Pathol. 2013 Nov;183(5):1527-38. doi: 10.1016/j.ajpath.2013.07.032.

14.

Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.

Carozzi VA, Renn CL, Bardini M, Fazio G, Chiorazzi A, Meregalli C, Oggioni N, Shanks K, Quartu M, Serra MP, Sala B, Cavaletti G, Dorsey SG.

PLoS One. 2013 Sep 12;8(9):e72995. doi: 10.1371/journal.pone.0072995. eCollection 2013.

15.

CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.

Meregalli C, Ceresa C, Canta A, Carozzi VA, Chiorazzi A, Sala B, Oggioni N, Lanza M, Letari O, Ferrari F, Avezza F, Marmiroli P, Caselli G, Cavaletti G.

J Pain Res. 2012;5:151-67. doi: 10.2147/JPR.S32122. Epub 2012 Jun 20.

16.

Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model.

Chiorazzi A, Höchel J, Stöckigt D, Canta A, Carozzi VA, Meregalli C, Avezza F, Crippa L, Sala B, Ceresa C, Oggioni N, Cavaletti G.

Neurotox Res. 2012 Aug;22(2):91-101. doi: 10.1007/s12640-011-9302-7. Epub 2011 Dec 22.

PMID:
22190114
17.

Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy.

Gilardini A, Avila RL, Oggioni N, Rodriguez-Menendez V, Bossi M, Canta A, Cavaletti G, Kirschner DA.

Neurotoxicology. 2012 Jan;33(1):1-7. doi: 10.1016/j.neuro.2011.10.010. Epub 2011 Nov 4.

PMID:
22079976
18.

Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy.

Bianchi R, Cervellini I, Porretta-Serapiglia C, Oggioni N, Burkey B, Ghezzi P, Cavaletti G, Lauria G.

J Pharmacol Exp Ther. 2012 Jan;340(1):64-72. doi: 10.1124/jpet.111.181529. Epub 2011 Oct 7.

PMID:
21984837
19.

In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™).

Canta A, Chiorazzi A, Carozzi V, Meregalli C, Oggioni N, Sala B, Crippa L, Avezza F, Forestieri D, Rotella G, Zucchetti M, Cavaletti G.

Cancer Chemother Pharmacol. 2011 Oct;68(4):1001-8. doi: 10.1007/s00280-011-1574-3. Epub 2011 Feb 16.

PMID:
21327681
20.

Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.

Carozzi VA, Canta A, Oggioni N, Sala B, Chiorazzi A, Meregalli C, Bossi M, Marmiroli P, Cavaletti G.

Exp Neurol. 2010 Dec;226(2):301-9. doi: 10.1016/j.expneurol.2010.09.004. Epub 2010 Sep 9.

PMID:
20832406
21.

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

Cervellini I, Bello E, Frapolli R, Porretta-Serapiglia C, Oggioni N, Canta A, Lombardi R, Camozzi F, Roglio I, Melcangi RC, D'incalci M, Lauria G, Ghezzi P, Cavaletti G, Bianchi R.

Neurotox Res. 2010 Aug;18(2):151-60. doi: 10.1007/s12640-009-9127-9. Epub 2009 Oct 30.

PMID:
19876698
22.

Regression of diabetic complications by islet transplantation in the rat.

Remuzzi A, Cornolti R, Bianchi R, Figliuzzi M, Porretta-Serapiglia C, Oggioni N, Carozzi V, Crippa L, Avezza F, Fiordaliso F, Salio M, Lauria G, Lombardi R, Cavaletti G.

Diabetologia. 2009 Dec;52(12):2653-61. doi: 10.1007/s00125-009-1537-y. Epub 2009 Sep 30.

PMID:
19789851
23.

Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.

Meregalli C, Canta A, Carozzi VA, Chiorazzi A, Oggioni N, Gilardini A, Ceresa C, Avezza F, Crippa L, Marmiroli P, Cavaletti G.

Eur J Pain. 2010 Apr;14(4):343-50. doi: 10.1016/j.ejpain.2009.07.001. Epub 2009 Aug 19.

PMID:
19695912
24.

Continuous buprenorphine delivery effect in streptozotocine-induced painful diabetic neuropathy in rats.

Canta A, Chiorazzi A, Meregalli C, Carozzi V, Oggioni N, Lauria G, Lombardi R, Bianchi R, Porretta-Serapiglia C, Cavaletti G.

J Pain. 2009 Sep;10(9):961-8. doi: 10.1016/j.jpain.2009.04.003.

PMID:
19595641
25.

Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies.

Chiorazzi A, Nicolini G, Canta A, Oggioni N, Rigolio R, Cossa G, Lombardi R, Roglio I, Cervellini I, Lauria G, Melcangi RC, Bianchi R, Crippa D, Cavaletti G.

Neurobiol Dis. 2009 Aug;35(2):270-7. doi: 10.1016/j.nbd.2009.05.006. Epub 2009 May 21.

PMID:
19464369
26.

Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis.

Cavaletti G, Cassetti A, Canta A, Galbiati S, Gilardini A, Oggioni N, Rodriguez-Menendez V, Fasano A, Liuzzi GM, Fattler U, Ries S, Nieland J, Riccio P, Haas H.

Mol Pharm. 2009 Sep-Oct;6(5):1363-70. doi: 10.1021/mp8001478.

PMID:
19281192
27.

Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity.

Carozzi V, Chiorazzi A, Canta A, Oggioni N, Gilardini A, Rodriguez-Menendez V, Avezza F, Crippa L, Ceresa C, Nicolini G, Bossi M, Cavaletti G.

Eur J Cancer. 2009 Mar;45(4):656-65. doi: 10.1016/j.ejca.2008.10.038. Epub 2008 Dec 16.

PMID:
19091544
28.

Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system.

Carozzi VA, Canta A, Oggioni N, Ceresa C, Marmiroli P, Konvalinka J, Zoia C, Bossi M, Ferrarese C, Tredici G, Cavaletti G.

J Anat. 2008 Nov;213(5):539-46. doi: 10.1111/j.1469-7580.2008.00984.x.

29.

Actively induced EAE in Lewis rats: characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease.

Rigolio R, Biffi A, Oggioni N, Cavaletti G.

J Neuroimmunol. 2008 Aug 13;199(1-2):67-74. doi: 10.1016/j.jneuroim.2008.05.008. Epub 2008 Jun 24.

PMID:
18572253
30.

Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study.

Rodriguez-Menendez V, Gilardini A, Bossi M, Canta A, Oggioni N, Carozzi V, Tremolizzo L, Cavaletti G.

Anticancer Res. 2008 Jan-Feb;28(1A):335-42.

31.

Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone.

Cavalletti E, Crippa L, Mainardi P, Oggioni N, Cavagnoli R, Bellini O, Sala F.

Invest New Drugs. 2007 Jun;25(3):187-95.

PMID:
17285358
32.

Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth.

Bianchi R, Gilardini A, Rodriguez-Menendez V, Oggioni N, Canta A, Colombo T, De Michele G, Martone S, Sfacteria A, Piedemonte G, Grasso G, Beccaglia P, Ghezzi P, D'Incalci M, Lauria G, Cavaletti G.

Eur J Cancer. 2007 Mar;43(4):710-7. Epub 2007 Jan 23.

PMID:
17251006
33.

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

Cavaletti G, Gilardini A, Canta A, Rigamonti L, Rodriguez-Menendez V, Ceresa C, Marmiroli P, Bossi M, Oggioni N, D'Incalci M, De Coster R.

Exp Neurol. 2007 Mar;204(1):317-25. Epub 2007 Jan 9.

PMID:
17214983
34.

Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.

Bianchi R, Brines M, Lauria G, Savino C, Gilardini A, Nicolini G, Rodriguez-Menendez V, Oggioni N, Canta A, Penza P, Lombardi R, Minoia C, Ronchi A, Cerami A, Ghezzi P, Cavaletti G.

Clin Cancer Res. 2006 Apr 15;12(8):2607-12.

35.

Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis.

Mazzanti B, Biagioli T, Aldinucci A, Cavaletti G, Cavalletti E, Oggioni N, Frigo M, Rota S, Tagliabue E, Ballerini C, Massacesi L, Riccio P, Lolli F.

J Neuroimmunol. 2005 Nov;168(1-2):111-7. Epub 2005 Aug 24.

PMID:
16120465
36.

Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells.

Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Braga M, Lolli F, Riccio P, Carlone G, Zoia C, Tagliabue E, Stanzani L, Galbiati S, Rigamonti L, Marmiroli P, Ferrarese C, Frattola L, Tredici G.

J Biol Regul Homeost Agents. 2004 Jan-Mar;18(1):9-17.

PMID:
15323355
37.

Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis.

Cavaletti G, Cavalletti E, Crippa L, Di Luccio E, Oggioni N, Mazzanti B, Biagioli T, Sala F, Sala V, Frigo M, Rota S, Tagliabue E, Stanzani L, Galbiati S, Rigolio R, Zoia C, Tredici G, Perseghin P, Dassi M, Riccio P, Lolli F.

J Neuroimmunol. 2004 Jun;151(1-2):55-65.

PMID:
15145604
38.

Erythropoietin both protects from and reverses experimental diabetic neuropathy.

Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A, Ghezzi P.

Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):823-8. Epub 2004 Jan 12.

39.

Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor.

Cavaletti G, Pezzoni G, Pisano C, Oggioni N, Sala F, Zoia C, Ferrarese C, Marmiroli P, Tredici G.

Neurosci Lett. 2002 Apr 5;322(2):103-6.

PMID:
11958854
40.

Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats.

Cavaletti G, Perseghin P, Dassi M, Oggioni N, Sala F, Lolli F, Riccio P, Tredici G, Frattola L.

J Neurol. 2001 Jun;248(6):535-6. No abstract available.

PMID:
11499650
41.

Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis.

Cavaletti G, Perseghin P, Buscemi F, Dassi M, Oggioni N, Sala F, Lolli F, Liuzzi GM, Riccio P, Frattola L, Tredici G.

Int J Tissue React. 2001;23(1):21-31.

PMID:
11392060
42.

Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study.

Cavaletti G, Oggioni N, Sala F, Pezzoni G, Cavalletti E, Marmiroli P, Petruccioli MG, Frattola L, Tredici G.

Toxicol Lett. 2000 Dec 20;118(1-2):103-7.

PMID:
11137315
43.

Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration.

Cavaletti G, Cavalletti E, Oggioni N, Sottani C, Minoia C, D'Incalci M, Zucchetti M, Marmiroli P, Tredici G.

Neurotoxicology. 2000 Jun;21(3):389-93.

PMID:
10894128
44.

Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat.

Cavaletti G, Cavalletti E, Montaguti P, Oggioni N, De Negri O, Tredici G.

Neurotoxicology. 1997;18(1):137-45.

PMID:
9215996
45.

Effects of moguisteine, a peripheral nonnarcotic antitussive agent, on airway inflammation in guinea-pigs in vivo.

Gallico L, Oggioni N, Dalla Rosa C, Ceserani R, Tognella S.

Eur Respir J. 1996 Mar;9(3):478-85.

Supplemental Content

Loading ...
Support Center